Respiratory Diseases in Cyclophosphamide-Treated Mice I. Increased Virulence of Mycoplasma pulmonis

AUTOR(ES)

Singer, S. H.

RESUMO

Mice infected intranasally with Mycoplasma pulmonis were treated with cyclophosphamide, a potent immunologic suppressor. In place of a chronic smouldering infection with little mortality (2%), a rapidly lethal infection with high mortality (66%) was produced. M. pulmonis was able to be isolated from several organs during the course of the unmodified infection. In the infected animals treated with cyclophosphamide, dissemination occurred earlier, and higher titers of mycoplasma were found. Reconstitution experiments with spleen cells from previously infected animals reversed the effect of cyclophosphamide, indicating that immunity plays an important role in containment of the infection and eventual recovery.

Documentos Relacionados

• Respiratory Diseases in Cyclophosphamide-Treated Mice II. Decreased Virulence of PR8 Influenza Virus
• Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats.
• Brain vascular endothelial cells express JC virus large tumor antigen in immunocompetent and cyclophosphamide-treated hamsters.
• Differences in virulence for mice among strains of Mycoplasma pulmonis.
• Pneumonia Due to Mycoplasma in Gnotobiotic Mice I. Pathogenicity of Mycoplasma pneumoniae, Mycoplasma salivarium, and Mycoplasma pulmonis for the Lungs of Conventional and Gnotobiotic Mice